In addition to CpG oligodeoxynucleotides, other immune adjuvants, such as stimulator of interferon (IFN) genes (STING) agonist, have also been developed as nanovaccines to combine with ionizing radiation for improving the cancer immunotherapy [72]. This evidence concerns the gene STING1 and cancer.